Article ID Journal Published Year Pages File Type
5698730 Clinical Oncology 2014 9 Pages PDF
Abstract
4DCT can theoretically improve therapeutic ratio and dose escalation based on dosimetric parameters and mathematical modelling. However, when individual characteristics are incorporated, this gain may be less evident in terms of survival and dyspnoea rates. 4DCT allows potential for isotoxic dose escalation, which may lead to improved local control and better overall survival.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , , , , , ,